Moving Forward on Implementing National Pharmacare
Federal Budget 2019 March 19, 2019
Guided by the consultations and interim report of the Advisory Council on the Implementation of National Pharmacare, Budget 2019 announces the Government’s intention to move forward on three foundational elements of national pharmacare.
To make prescription drugs more affordable and more accessible to more Canadians, the Government intends to work with its partners on the creation of: The Canadian Drug Agency, a new national drug agency that would build on existing provincial and territorial successes, and take a coordinated approach to assessing effectiveness and negotiating prescription drug prices on behalf of Canadians. Negotiating better prices could help lower the cost of prescription drugs for Canadians by up to $3 billion per year in the long term. A national formulary—a comprehensive, evidence-based list of prescribed drugs, to be developed as part of the Canadian Drug Agency. This would provide the basis for a consistent approach to formulary listing and patient access across the country. A national strategy for high-cost drugs for rare diseases to help Canadians get better access to the effective treatments they need. This is an important first step in expanding drug coverage through federal support.